SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

FDC - Quaterly Results

06 Nov 2024 Evaluate
The revenue for the September 2024 quarter is pegged at Rs. 5051.04 millions, about 5.30% up against Rs. 4796.98 millions recorded during the year-ago period.Profit for the quarter ended September 2024 increased merely by2.68% to Rs. 739.73  millions from Rs. 720.41 millions.OP of the company witnessed a marginal growth to 1070.78 millions from 1060.95 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 5051.04 4796.98 5.30 11292.45 10097.38 11.84 19161.87 17770.32 7.83
Other Income 346.78 273.85 26.63 628.31 571.69 9.90 1032.16 539.12 91.45
PBIDT 1070.78 1060.95 0.93 2769.24 2558.85 8.22 4416.74 3084.87 43.17
Interest 10.71 10.51 1.90 23.63 20.89 13.12 40.00 40.39 -0.97
PBDT 1060.07 1050.44 0.92 2745.61 2537.96 8.18 4376.74 3044.48 43.76
Depreciation 137.58 98.13 40.20 247.53 194.01 27.59 397.29 387.58 2.51
PBT 922.49 952.31 -3.13 2498.08 2343.95 6.58 3979.45 2656.90 49.78
TAX 182.76 231.90 -21.19 608.46 538.03 13.09 907.82 647.25 40.26
Deferred Tax -17.24 16.71 -203.17 48.46 17.84 171.64 51.63 -42.75 -220.77
PAT 739.73 720.41 2.68 1889.62 1805.92 4.63 3071.63 2009.65 52.84
Equity 162.81 162.81 0.00 162.81 165.91 -1.87 162.81 165.91 -1.87
PBIDTM(%) 21.20 22.12 -4.15 24.52 25.34 -3.23 23.05 17.36 32.78

FDC Share Price

369.55 -2.75 (-0.74%)
24-Apr-2026 13:13 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1620.65
Dr. Reddys Lab 1327.70
Cipla 1301.15
Zydus Lifesciences 929.50
Lupin 2279.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×